DREAMED DIABETES
DreaMed Diabetes is a medical device, SaaS company providing personalized diabetes treatment optimization solutions. The company was established in 2014, commercializing the first artificial pancreas technology which was published in the NEJM. Eversince, DreaMed Diabetes has been vigorously working on decision support tools in the diabetes management space and became the first and only company in the world to receive FDA clearance for a decision support system using data from CGM/SMBG and insuli... n pumps. We offer a clinically proven decision support system for insulin titration in type 1 diabetes patients. Our Advisor Pro software was created by diabetes professionals and is based on real-world experience, turbo-charged by artificial intelligence. Using it, any healthcare professional can analyze patient data in seconds and advise on the optimal treatment plan. By frequent titration changes and online monitoring, we allow patients better treatment thus by lowering their A1C levels and risk for complications. Using the Advisor Pro physicians and nurses can provide true patient-centered care and everyone can receive the same top-level of treatment – wherever they are and whoever their caregiver is.
DREAMED DIABETES
Industry:
Artificial Intelligence Biotechnology Diabetes Enterprise Software Health Care Medical Device
Founded:
2014-01-01
Address:
Petah Tiqva, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.dreamed-diabetes.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Sitelinks Search Box Euro Amazon
Similar Organizations
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Cnoga Medical
Cnoga Medical empowers people with easy-to-use, non-invasive medical devices.
DermAI
DermAI focuses on leveraging AI to improve skincare by offering online skin consultations.
iHealth Labs
iHealth offers cloud-based, personal healthcare products for individuals of all ages to take a more active role in managing their health.
iLoF - Intelligent Lab on Fiber
iLoF - Intelligent Lab on Fiber is enabling a new era of personalized, precision medicine.
Pristine Surgical
Pristine Surgical is develops a first-of-its-kind, single-use visualization platform for surgical, diagnostic rigid endoscopic procedures.
Sinocelltech
Sinocelltech is a biotech company that develops and manufactures recombinant proteins, monoclonal antibodies, and vaccines.
SyMap Medical
SyMap Medical is an innovative medical device company.
Current Employees Featured
Founder
Investors List
The Leona M. and Harry B. Helmsley Charitable Trust
The Leona M. and Harry B. Helmsley Charitable Trust investment in Grant - DreaMed Diabetes
Millhouse
Millhouse investment in Venture Round - DreaMed Diabetes
Medtronic
Medtronic investment in Seed Round - DreaMed Diabetes
Official Site Inspections
http://www.dreamed-diabetes.com Semrush global rank: 1.41 M Semrush visits lastest month: 20.01 K
- Host name: 52.247.83.34.bc.googleusercontent.com
- IP address: 34.83.247.52
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "DreaMed Diabetes"
Clinically Proven AI Powered Diabetes Technology | dreamed
DreaMed’s first product launch is endo.digital, a cloud-based SAAS platform that gives care provider organizations an end-to-end diabetes care pathway that can be deployed across all …See details»
FDA Cleared AI Powered Decision Support System | dreamed
Since then, DreaMed Diabetes has dedicated itself to developing decision-support tools in the diabetes management field. We are the world’s first and only company to receive FDA …See details»
DreaMed Diabetes - Crunchbase Company Profile
DreaMed Diabetes is a medical device, SaaS company providing personalized diabetes treatment optimization solutions. The company was established in 2014, commercializing the first artificial pancreas technology which was published in …See details»
Israeli startup offers hope in global diabetes crisis - The Times of …
Jan 26, 2022 The platform created by DreaMed Diabetes uses artificial intelligence to help doctors provide expert care for millions of patients with Type 1 and Type 2 diabetes despite a …See details»
DreaMed Diabetes - Org Chart, Teams, Culture & Jobs | The Org
View DreaMed Diabetes' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
DreaMed Diabetes - VentureRadar
"DreaMed Diabetes develops health solutions and decision support tools using algorithms for the optimization of intensive insulin therapy for the benefit of people with Type 1 and Type 2 …See details»
AI-Based Decision Support System for Optimal Diabetes …
Mar 9, 2022 AI driven clinical decision support system enabling any provider of diabetes care to deliver expert level treatment recommendations both in clinic and in between visits.See details»
DreaMed Diabetes - Updates, News, Events, Signals & Triggers
DreaMed Diabetes raised $5,000,000 / Grant from The Leona M. and Harry B. Helmsley Charitable Trust Discover more funding rounds Apr 20, 2020 Silicon Canals — This AI virtual …See details»
DreaMed Diabetes - Leadership Team | The Org
The Leadership Team at DreaMed Diabetes is responsible for setting the strategic vision and direction of the company, guiding innovation in diabetes management solutions. Composed of …See details»
DreaMed Diabetes Gets $5 Million Grant to Test Virtual …
The company will also operate decision support algorithms to optimize insulin treatment plans for people with type 1/type 2 diabetes on insulin pumps or multiple daily injections therapy. Because of its experience, products and …See details»
We have joined organizations across the... - DreaMed Diabetes
We have joined organizations across the world in a simple goal: tap in to the power of the global diabetes community to save lives. Together, we can lead the way in stopping the spread of …See details»
DreaMed receives 5th FDA Clearance
Oct 22, 2023 DreaMed receives 5th FDA Clearance. They have now expanded their ability to support expert level treatment plans for Type 2 Diabetes.See details»
DREAMED DIABETES: New FDA Clearance Paves The Way to …
Sep 17, 2019 About DreaMed Diabetes DreaMed Diabetes develops solutions and personalized decision support solutions for the optimization of insulin therapy for people with Type 1 and …See details»
Diabetes Affects Millions Across the U.S., DreaMed Makes …
Jun 6, 2022 DreaMed Diabetes is creating medical technology to alleviate therapeutic inertia for patients living with type 1 and type 2 diabetes. Read on to know more.See details»
DreaMed Receives FDA Clearance for its Type 2 Diabetes AI-based ...
Oct 6, 2021 DreaMed has done significant clinical research to achieve a strong AI-based clinical decision support system that has just received the necessary FDA clearance.See details»
DreaMed Launches its FDA-Cleared Diabetes Management …
Oct 20, 2021 Advisor Pro by DreaMed is an Al Clinical Decision Support System for diabetes, providing remote insulin management with data analysis and therapy management tools.See details»
DreaMed Simplifies Diabetes Care via AI-Driven Recommendations
Jun 23, 2023 This Israeli-born startup is making significant clinical and regulatory headway in their effort to automate care recommendations for people with diabetes. Their platform …See details»
DreaMed Expands Its Remote Diabetes Solution to Four Clinics …
Sep 30, 2020 From Hassenfeld Children’s Hospital at NYU Langone to Billings Clinic, and UF Health, DreaMed will integrate its remote insulin management solution into the protocols of …See details»
DreaMed Diabetes - Lucidity Insights
Aug 19, 2024 AI that transforms patient data into expert level treatment recommendations. DreaMed technology is cleared by the FDA, so care providers and patients can trust the …See details»
DreaMed Diabetes Raises $3 Million and Partners with Abbott for …
Aug 20, 2024 Israeli AI-driven diabetes platform DreaMed raises $3M, led by eHealth Ventures, bolstering commercialization with Abbott data integration and FDA approvals.See details»